跳轉至內容
Merck
全部照片(1)

文件

T3006

Supelco

庚酸睾酮

analytical standard

同義詞:

17β-羟基-4-雄甾烯-3-酮-17-庚酸酯, 4-雄甾烯-17β-醇-3-酮-17-庚酸酯, 睾酮-17β-庚酸酯

登入查看組織和合約定價
全部照片(1)

About This Item

經驗公式（希爾表示法）:
C26H40O3
CAS號碼:
315-37-7
分子量：:
400.59
EC號碼:
206-253-5
MDL號碼:
MFCD00055890
分類程式碼代碼:
41116107
PubChem物質ID:
329826733
NACRES:
NA.24

等級

analytical standard

品質等級

200

藥物控制

USDEA Schedule III; Home Office Schedule 4.2; regulated under CDSA - not available from Sigma-Aldrich Canada

技術

HPLC: suitable
gas chromatography (GC): suitable

應用

forensics and toxicology
veterinary

格式

neat

儲存溫度

2-8°C

SMILES 字串

CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

InChI

1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1

InChI 密鑰

VOCBWIIFXDYGNZ-IXKNJLPQSA-N

基因資訊

human ... AR(367)

尋找類似的產品？ 前往 產品比較指南

相關類別

一般說明

Testosterone enanthate is a testosterone ester, which is widely used in hormone replacement therapy.

應用

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

象形圖

Health hazardExclamation mark
GHS08,GHS07

訊號詞

Danger

危險聲明

H302,H350,H361

危險分類

Acute Tox. 4 Oral - Carc. 1B - Repr. 2

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

個人防護裝備

Eyeshields, Gloves, type P3 (EN 143) respirator cartridges

Choose from one of the most recent versions:

分析證明 (COA)

Lot/Batch Number
0000305202
0000249859
0000276670
SLCL0116
SLCD4374

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate as assessed by serum and salivary testosterone levels in normal men.
Schurmeryer T and Nieschlag E.
International Journal of Andrology, 7(3), 181-187 (1984)
Andrology: Male Reproductive Health and Dysfunction (2010)
Séverine Trabado et al.
Fertility and sterility, 95(7), 2324-2329 (2011-05-04)
To evaluate the degree of E2 deficiency in male congenital hypogonadotropic hypogonadism (CHH), and its response to different hormonal treatments. Retrospective and prospective studies. Academic institution. Untreated or treated CHH, healthy men, untreated men with Klinefelter syndrome (KS). Serum sex
A F Radicioni et al.
Clinical endocrinology, 76(1), 72-77 (2011-07-02)
Hypogonadism in Prader-Willi syndrome (PWS) is generally attributed to hypothalamic dysfunction or to primary gonadal defect, but pathophysiology is still unclear. To investigate the aetiology of hypothalamic-pituitary-gonadal axis dysfunction in PWS males. Clinical examination and blood sampling for luteinizing hormone
Shane Rogerson et al.
Journal of strength and conditioning research, 21(2), 354-361 (2007-05-29)
Use of testosterone enanthate has been shown to significantly increase strength within 6-12 weeks of administration (2, 9), however, it is unclear if the ergogenic benefits are evident in less than 6 weeks. Testosterone enanthate is classified as a prohibited
查看所有相關論文

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務